TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/16/25 08:27 | 6/12/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | 2 | P | 16 | 0.4955 | 0 | 33 | 1 | 3,374 | D | ||||||||||||||
6/12/25 17:09 | 6/12/25 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gathagan Bryan K. | ME | D | 1 | P | 6 | 6.32 | 0 | 1 | 1 | D | ||||||||||||||||
6/4/25 07:55 | 6/3/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | 1 | P | 11 | 0.5386 | 0 | 20 | 1 | 3,263 | D | |||||||||||||||
5/19/25 13:23 | 5/19/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | 1 | P | 22 | 0.4300 | 0 | 50 | 11 | 519 | D | ||||||||||||||
5/12/25 14:30 | 5/12/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Gupta Aashima | MI | D | 1 | P | 100 | 6.25 | 0 | 16 | 270 | 22 | D | |||||||||||||||
4/25/25 16:32 | 4/25/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Woteki Catherine E | MI | D | 1 | P | 30 | 5.17 | 0 | 6 | 77 | 13 | D | |||||||||||||||
4/25/25 14:45 | 4/24/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | MI | D | 1 | P | 150 | 4.99 | 0 | 30 | 50 | 90 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |